deltatrials
Active Not Recruiting PHASE2 INTERVENTIONAL 1-arm NCT03614949

SBRT and Atezolizumab in the Management of Recurrent, Persistent, or Metastatic Cervical Cancer

Phase II Study of Stereotactic Body Radiation Therapy and Atezolizumab in the Management of Recurrent, Persistent, or Metastatic Cervical Cancer

Sponsor: Genentech, Inc.

Conditions Cervical Cancer Cervical Cancer Metastatic Cervical Cancer Recurrent
Interventions Atezolizumab Stereotactic body radiation therapy (SBRT)
Updated 30 times since 2018 Last updated: Dec 17, 2025 Started: Jan 29, 2019 Primary completion: Oct 31, 2028 Completion: Oct 31, 2028
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Cervical Cancer and Cervical Cancer Metastatic and is currently ongoing. Genentech, Inc. leads this study, which shows 30 recorded versions since 2019 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Sep 2018 – ~Dec 2018 · 3 months · monthly snapshot~Dec 2018 – ~Jan 2019 · 31 days · monthly snapshot~Jan 2019 – ~Feb 2019 · 31 days · monthly snapshot~Feb 2019 – ~Jul 2019 · 5 months · monthly snapshot~Jul 2019 – ~Dec 2019 · 5 months · monthly snapshot~Dec 2019 – ~Feb 2020 · 2 months · monthly snapshot~Feb 2020 – ~May 2020 · 3 months · monthly snapshot~May 2020 – ~Oct 2020 · 5 months · monthly snapshot~Oct 2020 – ~Jan 2021 · 3 months · monthly snapshot~Jan 2021 – ~Mar 2021 · 59 days · monthly snapshot~Mar 2021 – ~Apr 2021 · 31 days · monthly snapshot~Apr 2021 – ~Sep 2021 · 5 months · monthly snapshot~Sep 2021 – ~Feb 2022 · 5 months · monthly snapshot~Feb 2022 – ~Jul 2022 · 5 months · monthly snapshot~Jul 2022 – ~Sep 2022 · 2 months · monthly snapshot~Sep 2022 – ~Dec 2022 · 3 months · monthly snapshot~Dec 2022 – ~Feb 2023 · 2 months · monthly snapshot~Feb 2023 – ~Apr 2023 · 59 days · monthly snapshot~Apr 2023 – ~Jun 2023 · 2 months · monthly snapshot~Jun 2023 – ~Nov 2023 · 5 months · monthly snapshot~Nov 2023 – ~Apr 2024 · 5 months · monthly snapshot~Apr 2024 – ~Jul 2024 · 3 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Jan 2025 · 4 months · monthly snapshot~Jan 2025 – ~Apr 2025 · 3 months · monthly snapshot~Apr 2025 – ~Jun 2025 · 2 months · monthly snapshot~Jun 2025 – ~Jul 2025 · 30 days · monthly snapshot~Jul 2025 – ~Nov 2025 · 4 months · monthly snapshot~Nov 2025 – ~Jan 2026 · 2 months · monthly snapshot~Jan 2026 – present · 6 months · monthly snapshot

Change History

30 versions recorded

  1. Jan 2026 — Present [monthly]

    Active Not Recruiting PHASE2

  2. Nov 2025 — Jan 2026 [monthly]

    Active Not Recruiting PHASE2

  3. Jul 2025 — Nov 2025 [monthly]

    Active Not Recruiting PHASE2

  4. Jun 2025 — Jul 2025 [monthly]

    Active Not Recruiting PHASE2

  5. Apr 2025 — Jun 2025 [monthly]

    Active Not Recruiting PHASE2

    Status: Recruiting → Active Not Recruiting

▶ Show 25 earlier versions

  1. Jan 2025 — Apr 2025 [monthly]

    Recruiting PHASE2

  2. Sep 2024 — Jan 2025 [monthly]

    Recruiting PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE2

  4. Apr 2024 — Jul 2024 [monthly]

    Recruiting PHASE2

  5. Nov 2023 — Apr 2024 [monthly]

    Recruiting PHASE2

  6. Jun 2023 — Nov 2023 [monthly]

    Recruiting PHASE2

  7. Apr 2023 — Jun 2023 [monthly]

    Recruiting PHASE2

  8. Feb 2023 — Apr 2023 [monthly]

    Recruiting PHASE2

  9. Dec 2022 — Feb 2023 [monthly]

    Recruiting PHASE2

  10. Sep 2022 — Dec 2022 [monthly]

    Recruiting PHASE2

  11. Jul 2022 — Sep 2022 [monthly]

    Recruiting PHASE2

  12. Feb 2022 — Jul 2022 [monthly]

    Recruiting PHASE2

  13. Sep 2021 — Feb 2022 [monthly]

    Recruiting PHASE2

  14. Apr 2021 — Sep 2021 [monthly]

    Recruiting PHASE2

  15. Mar 2021 — Apr 2021 [monthly]

    Recruiting PHASE2

  16. Jan 2021 — Mar 2021 [monthly]

    Recruiting PHASE2

  17. Oct 2020 — Jan 2021 [monthly]

    Recruiting PHASE2

  18. May 2020 — Oct 2020 [monthly]

    Recruiting PHASE2

  19. Feb 2020 — May 2020 [monthly]

    Recruiting PHASE2

  20. Dec 2019 — Feb 2020 [monthly]

    Recruiting PHASE2

  21. Jul 2019 — Dec 2019 [monthly]

    Recruiting PHASE2

  22. Feb 2019 — Jul 2019 [monthly]

    Recruiting PHASE2

    Status: Not Yet Recruiting → Recruiting

  23. Jan 2019 — Feb 2019 [monthly]

    Not Yet Recruiting PHASE2

  24. Dec 2018 — Jan 2019 [monthly]

    Not Yet Recruiting PHASE2

  25. Sep 2018 — Dec 2018 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Genentech, Inc.
  • H. Lee Moffitt Cancer Center and Research Institute
Data source: H. Lee Moffitt Cancer Center and Research Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations